MitoQ, a commercial antioxidant drug that acts on mitochondria, may protect nerve cells in multiple sclerosis.

This is evidenced by the results of experiments conducted by Portland scientists..

Mitochondrial dysfunction and accumulation of reactive oxygen species linked to axonal damage in multiple sclerosis.

Researchers at the University of Portland Health Sciences (Oregon), led by Dr. Hemachandra Reddy, decided to give MitoQ (mitochondrial coenzyme Q10) to mice with induced encephalomyelitis, a common model of MS..

With MitoQ treatment, the clinical and behavioral manifestations of the disease occurred later, while without treatment, neurological consequences, including paralysis of the limbs, developed within 2 weeks..

Further analysis showed that MitoQ reduces inflammation in the brain and spinal cord of animals, protecting neurons from rapid demyelination and cytotoxic events..

In Biochimica et Biophysica Acta, scientists wrote that MitoQ "

medbe. en.